Interleukine-15 et contrôle de l'hématopoïèse

Translated title of the contribution: Interleukin-15 and hematopoiesis

Julien Giron-Michel, Danièle Brouty-Boyé, M. C. Le Bousse-Kerdilès, Anne Caignard, Salem Chouaib, Bruno Azzarone

Research output: Contribution to journalArticle

Abstract

Interleukin-15 (11-15) is a cytokine present under different forms (secreted, membrane-bound, intracytoplasmic and nuclear) mediating different functions. Its receptor is composed of three chains (IL-15Rα/β /γc) displaying several different functional associations (IL-15Rα, IL-15Rα/β/γc, IL-15Rα/γc, IL-15Rα/γc). IL-15 is considered the most powerful physiological inducer of the differentiation of human hematopoietic progenitors (HP) into NK cells. It is likely that IL-15 could display a broader spectrum of regulatory functions on hematopoiesis more important than it has been previously suspected. Unprimed HP CD34+ cells constitutively secrete an endogenous, IL-15 (ES-IL-15) that controls, through autocrine/paracrine loops, several transcription factors and molecules playing a central role in the control of hematopoiesis. Nevertheless, ES-IL-15 is not competent for triggering HP differentiation into NK cells, likely due to the presence of a novel hybrid receptor composed of the γc and the GM-CSIFIRβ able to interfere on the signals of both IL-15 and GM-CSF. Finally, a novel type of membrane-bound IL-15 (IL-15mb) is expressed on human stromal spleen (derived myofibroblasts) and retained on the surface by the IL-15RIα/γc complex. Contact with this IL-15mb: 1) is necessary and sufficient for inducing the differentiation of circulating HP into cytolytic NK cells; 2) modifies the signalling pathways controlled by the ES-IL-15 in CB HP. Furthermore, IL-15mb signalling is heavily conditioned by the presence on surrounding cells of the IL-15Ra chain that activates some pathways (NFKB and STAT6), while inhibiting other (STAT3 et STAT5) that play a key role in the control of myelopoiesis. IL-15, through the cross-talk between its different forms and the different composition of IL-15R, could be one of the important regulatory factors of normal hematopoiesis. Alterations of these interactions could generate not only dysmyelopoiesis, but also survival and expansion of some leukemic clones.

Original languageFrench
Pages (from-to)135-145
Number of pages11
JournalHematologie
Volume10
Issue number2
Publication statusPublished - Mar 2004

Fingerprint

Interleukin-15
Hematopoiesis
Natural Killer Cells
Myelopoiesis
Interleukin-11
Membranes
Myofibroblasts
Granulocyte-Macrophage Colony-Stimulating Factor
Hematopoietic Stem Cells
Interleukin-1
Transcription Factors
Spleen
Clone Cells
Cytokines
Survival

Keywords

  • GM-CSF
  • IL-15
  • IL-15R
  • Signal transduction

ASJC Scopus subject areas

  • Hematology

Cite this

Giron-Michel, J., Brouty-Boyé, D., Le Bousse-Kerdilès, M. C., Caignard, A., Chouaib, S., & Azzarone, B. (2004). Interleukine-15 et contrôle de l'hématopoïèse. Hematologie, 10(2), 135-145.

Interleukine-15 et contrôle de l'hématopoïèse. / Giron-Michel, Julien; Brouty-Boyé, Danièle; Le Bousse-Kerdilès, M. C.; Caignard, Anne; Chouaib, Salem; Azzarone, Bruno.

In: Hematologie, Vol. 10, No. 2, 03.2004, p. 135-145.

Research output: Contribution to journalArticle

Giron-Michel, J, Brouty-Boyé, D, Le Bousse-Kerdilès, MC, Caignard, A, Chouaib, S & Azzarone, B 2004, 'Interleukine-15 et contrôle de l'hématopoïèse', Hematologie, vol. 10, no. 2, pp. 135-145.
Giron-Michel J, Brouty-Boyé D, Le Bousse-Kerdilès MC, Caignard A, Chouaib S, Azzarone B. Interleukine-15 et contrôle de l'hématopoïèse. Hematologie. 2004 Mar;10(2):135-145.
Giron-Michel, Julien ; Brouty-Boyé, Danièle ; Le Bousse-Kerdilès, M. C. ; Caignard, Anne ; Chouaib, Salem ; Azzarone, Bruno. / Interleukine-15 et contrôle de l'hématopoïèse. In: Hematologie. 2004 ; Vol. 10, No. 2. pp. 135-145.
@article{dae5a9eba7d34ecca0d02b51e1d99901,
title = "Interleukine-15 et contr{\^o}le de l'h{\'e}matopo{\"i}{\`e}se",
abstract = "Interleukin-15 (11-15) is a cytokine present under different forms (secreted, membrane-bound, intracytoplasmic and nuclear) mediating different functions. Its receptor is composed of three chains (IL-15Rα/β /γc) displaying several different functional associations (IL-15Rα, IL-15Rα/β/γc, IL-15Rα/γc, IL-15Rα/γc). IL-15 is considered the most powerful physiological inducer of the differentiation of human hematopoietic progenitors (HP) into NK cells. It is likely that IL-15 could display a broader spectrum of regulatory functions on hematopoiesis more important than it has been previously suspected. Unprimed HP CD34+ cells constitutively secrete an endogenous, IL-15 (ES-IL-15) that controls, through autocrine/paracrine loops, several transcription factors and molecules playing a central role in the control of hematopoiesis. Nevertheless, ES-IL-15 is not competent for triggering HP differentiation into NK cells, likely due to the presence of a novel hybrid receptor composed of the γc and the GM-CSIFIRβ able to interfere on the signals of both IL-15 and GM-CSF. Finally, a novel type of membrane-bound IL-15 (IL-15mb) is expressed on human stromal spleen (derived myofibroblasts) and retained on the surface by the IL-15RIα/γc complex. Contact with this IL-15mb: 1) is necessary and sufficient for inducing the differentiation of circulating HP into cytolytic NK cells; 2) modifies the signalling pathways controlled by the ES-IL-15 in CB HP. Furthermore, IL-15mb signalling is heavily conditioned by the presence on surrounding cells of the IL-15Ra chain that activates some pathways (NFKB and STAT6), while inhibiting other (STAT3 et STAT5) that play a key role in the control of myelopoiesis. IL-15, through the cross-talk between its different forms and the different composition of IL-15R, could be one of the important regulatory factors of normal hematopoiesis. Alterations of these interactions could generate not only dysmyelopoiesis, but also survival and expansion of some leukemic clones.",
keywords = "GM-CSF, IL-15, IL-15R, Signal transduction",
author = "Julien Giron-Michel and Dani{\`e}le Brouty-Boy{\'e} and {Le Bousse-Kerdil{\`e}s}, {M. C.} and Anne Caignard and Salem Chouaib and Bruno Azzarone",
year = "2004",
month = "3",
language = "Francese",
volume = "10",
pages = "135--145",
journal = "Hematologie",
issn = "1264-7527",
publisher = "John Libbey Eurotext",
number = "2",

}

TY - JOUR

T1 - Interleukine-15 et contrôle de l'hématopoïèse

AU - Giron-Michel, Julien

AU - Brouty-Boyé, Danièle

AU - Le Bousse-Kerdilès, M. C.

AU - Caignard, Anne

AU - Chouaib, Salem

AU - Azzarone, Bruno

PY - 2004/3

Y1 - 2004/3

N2 - Interleukin-15 (11-15) is a cytokine present under different forms (secreted, membrane-bound, intracytoplasmic and nuclear) mediating different functions. Its receptor is composed of three chains (IL-15Rα/β /γc) displaying several different functional associations (IL-15Rα, IL-15Rα/β/γc, IL-15Rα/γc, IL-15Rα/γc). IL-15 is considered the most powerful physiological inducer of the differentiation of human hematopoietic progenitors (HP) into NK cells. It is likely that IL-15 could display a broader spectrum of regulatory functions on hematopoiesis more important than it has been previously suspected. Unprimed HP CD34+ cells constitutively secrete an endogenous, IL-15 (ES-IL-15) that controls, through autocrine/paracrine loops, several transcription factors and molecules playing a central role in the control of hematopoiesis. Nevertheless, ES-IL-15 is not competent for triggering HP differentiation into NK cells, likely due to the presence of a novel hybrid receptor composed of the γc and the GM-CSIFIRβ able to interfere on the signals of both IL-15 and GM-CSF. Finally, a novel type of membrane-bound IL-15 (IL-15mb) is expressed on human stromal spleen (derived myofibroblasts) and retained on the surface by the IL-15RIα/γc complex. Contact with this IL-15mb: 1) is necessary and sufficient for inducing the differentiation of circulating HP into cytolytic NK cells; 2) modifies the signalling pathways controlled by the ES-IL-15 in CB HP. Furthermore, IL-15mb signalling is heavily conditioned by the presence on surrounding cells of the IL-15Ra chain that activates some pathways (NFKB and STAT6), while inhibiting other (STAT3 et STAT5) that play a key role in the control of myelopoiesis. IL-15, through the cross-talk between its different forms and the different composition of IL-15R, could be one of the important regulatory factors of normal hematopoiesis. Alterations of these interactions could generate not only dysmyelopoiesis, but also survival and expansion of some leukemic clones.

AB - Interleukin-15 (11-15) is a cytokine present under different forms (secreted, membrane-bound, intracytoplasmic and nuclear) mediating different functions. Its receptor is composed of three chains (IL-15Rα/β /γc) displaying several different functional associations (IL-15Rα, IL-15Rα/β/γc, IL-15Rα/γc, IL-15Rα/γc). IL-15 is considered the most powerful physiological inducer of the differentiation of human hematopoietic progenitors (HP) into NK cells. It is likely that IL-15 could display a broader spectrum of regulatory functions on hematopoiesis more important than it has been previously suspected. Unprimed HP CD34+ cells constitutively secrete an endogenous, IL-15 (ES-IL-15) that controls, through autocrine/paracrine loops, several transcription factors and molecules playing a central role in the control of hematopoiesis. Nevertheless, ES-IL-15 is not competent for triggering HP differentiation into NK cells, likely due to the presence of a novel hybrid receptor composed of the γc and the GM-CSIFIRβ able to interfere on the signals of both IL-15 and GM-CSF. Finally, a novel type of membrane-bound IL-15 (IL-15mb) is expressed on human stromal spleen (derived myofibroblasts) and retained on the surface by the IL-15RIα/γc complex. Contact with this IL-15mb: 1) is necessary and sufficient for inducing the differentiation of circulating HP into cytolytic NK cells; 2) modifies the signalling pathways controlled by the ES-IL-15 in CB HP. Furthermore, IL-15mb signalling is heavily conditioned by the presence on surrounding cells of the IL-15Ra chain that activates some pathways (NFKB and STAT6), while inhibiting other (STAT3 et STAT5) that play a key role in the control of myelopoiesis. IL-15, through the cross-talk between its different forms and the different composition of IL-15R, could be one of the important regulatory factors of normal hematopoiesis. Alterations of these interactions could generate not only dysmyelopoiesis, but also survival and expansion of some leukemic clones.

KW - GM-CSF

KW - IL-15

KW - IL-15R

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=2642519711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642519711&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:2642519711

VL - 10

SP - 135

EP - 145

JO - Hematologie

JF - Hematologie

SN - 1264-7527

IS - 2

ER -